vs
HALOZYME THERAPEUTICS, INC.（HALO）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是HALOZYME THERAPEUTICS, INC.的1.0倍（$461.6M vs $451.8M），RBC Bearings INC净利率更高（14.6% vs -31.3%，领先45.9%），HALOZYME THERAPEUTICS, INC.同比增速更快（51.6% vs 17.0%），HALOZYME THERAPEUTICS, INC.自由现金流更多（$217.6M vs $99.1M），过去两年HALOZYME THERAPEUTICS, INC.的营收复合增速更高（51.9% vs 5.6%）
Halozyme Therapeutics是一家美国生物技术企业，专注于肿瘤领域创新疗法研发，核心管线均针对肿瘤微环境进行靶向干预，致力于为全球癌症患者提供更安全高效的治疗选择。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
HALO vs RBC — 直观对比
营收规模更大
RBC
是对方的1.0倍
$451.8M
营收增速更快
HALO
高出34.6%
17.0%
净利率更高
RBC
高出45.9%
-31.3%
自由现金流更多
HALO
多$118.5M
$99.1M
两年增速更快
HALO
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $451.8M | $461.6M |
| 净利润 | $-141.6M | $67.4M |
| 毛利率 | 82.6% | 44.3% |
| 营业利润率 | -20.6% | 22.3% |
| 净利率 | -31.3% | 14.6% |
| 营收同比 | 51.6% | 17.0% |
| 净利润同比 | -203.3% | 16.4% |
| 每股收益（稀释后） | $-1.13 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HALORBC
| Q4 25 | $451.8M | $461.6M | ||
| Q3 25 | $354.3M | $455.3M | ||
| Q2 25 | $325.7M | $436.0M | ||
| Q1 25 | $264.9M | $437.7M | ||
| Q4 24 | $298.0M | $394.4M | ||
| Q3 24 | $290.1M | $397.9M | ||
| Q2 24 | $231.4M | $406.3M | ||
| Q1 24 | $195.9M | $413.7M |
净利润HALORBC
| Q4 25 | $-141.6M | $67.4M | ||
| Q3 25 | $175.2M | $60.0M | ||
| Q2 25 | $165.2M | $68.5M | ||
| Q1 25 | $118.1M | $72.7M | ||
| Q4 24 | $137.0M | $57.9M | ||
| Q3 24 | $137.0M | $54.2M | ||
| Q2 24 | $93.2M | $61.4M | ||
| Q1 24 | $76.8M | — |
毛利率HALORBC
| Q4 25 | 82.6% | 44.3% | ||
| Q3 25 | 84.4% | 44.1% | ||
| Q2 25 | 85.8% | 44.8% | ||
| Q1 25 | 81.7% | 44.2% | ||
| Q4 24 | 85.9% | 44.3% | ||
| Q3 24 | 83.0% | 43.7% | ||
| Q2 24 | 82.9% | 45.3% | ||
| Q1 24 | 85.5% | 43.1% |
营业利润率HALORBC
| Q4 25 | -20.6% | 22.3% | ||
| Q3 25 | 61.5% | 21.5% | ||
| Q2 25 | 62.2% | 23.2% | ||
| Q1 25 | 53.4% | 23.0% | ||
| Q4 24 | 58.9% | 21.7% | ||
| Q3 24 | 56.3% | 21.6% | ||
| Q2 24 | 50.7% | 24.0% | ||
| Q1 24 | 48.8% | 22.8% |
净利率HALORBC
| Q4 25 | -31.3% | 14.6% | ||
| Q3 25 | 49.5% | 13.2% | ||
| Q2 25 | 50.7% | 15.7% | ||
| Q1 25 | 44.6% | 16.6% | ||
| Q4 24 | 46.0% | 14.7% | ||
| Q3 24 | 47.2% | 13.6% | ||
| Q2 24 | 40.3% | 15.1% | ||
| Q1 24 | 39.2% | — |
每股收益（稀释后）HALORBC
| Q4 25 | $-1.13 | $2.13 | ||
| Q3 25 | $1.43 | $1.90 | ||
| Q2 25 | $1.33 | $2.17 | ||
| Q1 25 | $0.93 | $2.33 | ||
| Q4 24 | $1.06 | $1.82 | ||
| Q3 24 | $1.05 | $1.65 | ||
| Q2 24 | $0.72 | $1.90 | ||
| Q1 24 | $0.60 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.8M | $107.6M |
| 总债务越低越好 | $2.1B | $990.2M |
| 股东权益账面价值 | $48.8M | $3.3B |
| 总资产 | $2.5B | $5.1B |
| 负债/权益比越低杠杆越低 | 43.89× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资HALORBC
| Q4 25 | $133.8M | $107.6M | ||
| Q3 25 | $419.7M | $91.2M | ||
| Q2 25 | $61.9M | $132.9M | ||
| Q1 25 | $176.3M | $36.8M | ||
| Q4 24 | $115.8M | — | ||
| Q3 24 | $154.3M | — | ||
| Q2 24 | $187.9M | $76.8M | ||
| Q1 24 | $164.6M | $63.5M |
总债务HALORBC
| Q4 25 | $2.1B | $990.2M | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.5B | $915.6M | ||
| Q1 25 | $1.5B | $920.1M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | $1.2B |
股东权益HALORBC
| Q4 25 | $48.8M | $3.3B | ||
| Q3 25 | $503.9M | $3.2B | ||
| Q2 25 | $332.7M | $3.1B | ||
| Q1 25 | $482.3M | $3.0B | ||
| Q4 24 | $363.8M | $2.9B | ||
| Q3 24 | $452.7M | $2.9B | ||
| Q2 24 | $289.4M | $2.8B | ||
| Q1 24 | $177.8M | $2.8B |
总资产HALORBC
| Q4 25 | $2.5B | $5.1B | ||
| Q3 25 | $2.2B | $5.1B | ||
| Q2 25 | $2.1B | $4.8B | ||
| Q1 25 | $2.2B | $4.7B | ||
| Q4 24 | $2.1B | $4.7B | ||
| Q3 24 | $2.1B | $4.7B | ||
| Q2 24 | $2.0B | $4.7B | ||
| Q1 24 | $1.8B | $4.7B |
负债/权益比HALORBC
| Q4 25 | 43.89× | 0.30× | ||
| Q3 25 | 3.00× | 0.34× | ||
| Q2 25 | 4.54× | 0.29× | ||
| Q1 25 | 3.13× | 0.30× | ||
| Q4 24 | 4.14× | — | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — | ||
| Q1 24 | 8.44× | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $219.0M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $217.6M | $99.1M |
| 自由现金流率自由现金流/营收 | 48.2% | 21.5% |
| 资本支出强度资本支出/营收 | 0.3% | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | $644.6M | — |
8季度趋势，按日历期对齐
经营现金流HALORBC
| Q4 25 | $219.0M | $122.1M | ||
| Q3 25 | $178.6M | $88.4M | ||
| Q2 25 | $99.7M | $120.0M | ||
| Q1 25 | $154.2M | — | ||
| Q4 24 | $178.5M | $84.0M | ||
| Q3 24 | $115.4M | — | ||
| Q2 24 | $55.8M | $97.4M | ||
| Q1 24 | $129.4M | — |
自由现金流HALORBC
| Q4 25 | $217.6M | $99.1M | ||
| Q3 25 | $175.6M | $71.7M | ||
| Q2 25 | $98.1M | $104.3M | ||
| Q1 25 | $153.3M | — | ||
| Q4 24 | $175.4M | $73.6M | ||
| Q3 24 | $113.9M | — | ||
| Q2 24 | $53.2M | $88.4M | ||
| Q1 24 | $125.9M | — |
自由现金流率HALORBC
| Q4 25 | 48.2% | 21.5% | ||
| Q3 25 | 49.6% | 15.7% | ||
| Q2 25 | 30.1% | 23.9% | ||
| Q1 25 | 57.9% | — | ||
| Q4 24 | 58.9% | 18.7% | ||
| Q3 24 | 39.3% | — | ||
| Q2 24 | 23.0% | 21.8% | ||
| Q1 24 | 64.3% | — |
资本支出强度HALORBC
| Q4 25 | 0.3% | 5.0% | ||
| Q3 25 | 0.9% | 3.7% | ||
| Q2 25 | 0.5% | 3.6% | ||
| Q1 25 | 0.4% | 3.2% | ||
| Q4 24 | 1.0% | 2.6% | ||
| Q3 24 | 0.5% | 4.1% | ||
| Q2 24 | 1.1% | 2.2% | ||
| Q1 24 | 1.8% | — |
现金转化率HALORBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | 1.02× | 1.47× | ||
| Q2 25 | 0.60× | 1.75× | ||
| Q1 25 | 1.31× | — | ||
| Q4 24 | 1.30× | 1.45× | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.60× | 1.59× | ||
| Q1 24 | 1.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
